Reporting quality of randomized controlled trials of percutaneous patent foramen ovale closure for the treatment of migraine based on the CONSORT statement

26 August 2023 (14:15 - 15:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Eirini Beneki

Ippokrateio General Hospital of Athens, Athens (Greece)

5 More presentations in this session

Presentation thumbnail

Comparative analysis between transcranial doppler and transesophageal echocardiogram in diagnosing residual shunt after persistent foramen ovale closure

Doctor Y. Won (Incheon, KR)

Abstract Slides Video

Presentation thumbnail

Microtransesophageal echocardiographic guidance of patent foramen ovale percutaneous closure

Doctor N. Bouziri (Paris, FR)

Abstract Slides Video

Presentation thumbnail

Patent foramen ovale closure reduces migraine burden: a meta-analysis

Doctor E. Beneki (Athens, GR)

Abstract Slides Video

Presentation thumbnail

Long term follow-up of patent foramen closure due to embolic infarction in elderly patients

Doctor C. Hamm (Bad Nauheim, DE)

Abstract Slides Video

Presentation thumbnail

Long- term results of interventional treatment of paravalvular leaks after prosthetic valve replacement with plug devices. Results from a prospective registry.

Professor R. Zahn (Ludwigshafen, DE)

Abstract Slides

Access the full session

Session thumbnail

From patent foramen ovale to paravalvular leak closure…

The Event

Event poster

ESC Congress 2023

26 August 2023 14:15 CET

You may be interested in

Congress Presentation

Relationship of inflammatory factors with migraine in patients with patent foramen ovale undergoing percutaneous closure

Congress Presentation

Patent foramen ovale closure reduces migraine burden: a meta-analysis

Congress Presentation

Timing on patent foramen ovale closure: early versus delayed closure

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources